ORMP icon

Oramed Pharmaceuticals

28 hedge funds and large institutions have $8.45M invested in Oramed Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$4K
Net Calls
Net Calls Change

Top Buyers

1 +$3.88M
2 +$3.04M
3 +$88K
4
Group One Trading
Group One Trading
Illinois
+$82K
5
Squarepoint
Squarepoint
New York
+$71K

Top Sellers

1 -$59.7K
2 -$24.9K
3 -$5K
4
LC
Landaas & Company
Wisconsin
-$2K
5
Morgan Stanley
Morgan Stanley
New York
-$24
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.88M
2
$3.04M
3
$201K
4
$199K
5
$143K
6
$142K
7
$114K
8
$103K
9
$97K
10
$88K
11
$82K
12
$73K
13
$71K
14
$57K
15
$46K
16
$42K
17
$16K
18
$15K
19
$10K
20
$8K
21
$7K
22
$5K
23
$5K
24
$4K
25
$2K